Liquid biopsy, a blood-based test for diagnosing cancer, is gaining popularity over traditional tissue-based biopsies, say experts. The test analyses circulating tumour cells or cell-free DNA to diagnose or analyse tumours and cancer cells, and can also be used to monitor how well patients are responding to treatment. Several studies have identified liquid biopsies as the “future of early cancer detection”.